The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate.
The ability of pro-inflammatory cytokines such as interleukin-1beta (IL-1beta) to induce the major inflammatory mediator prostaglandin (PG) E(2) depends on the activation of two rate-limiting enzymes, phospholipase A(2) (PLA(2)) and cyclooxygenase 2 (COX-2). PLA(2) acts to generate arachidonic acid, which serves as the precursor substrate for COX-2 in the metabolic pathway leading to PGE(2) production. However, less is known about the mechanisms that coordinate the regulation of these two enzymes. We have provided prior evidence that sphingosine kinase 1 and its bioactive lipid product sphingosine-1-phosphate (S1P) mediate the effects of cytokines on COX-2 induction, whereas ceramide kinase and its distinct product, ceramide-1-phosphate (C1P), are required for the activation and translocation of cPLA(2) (FASEB J 17:1411-1421. 2003; J Biol Chem 278:38206-38213, 2003; J Biol Chem 279:11320-11326, 2004). Herein, we show that these two pathways are independent but coordinated, resulting in synergistic induction of PGE(2). Moreover, the combination of both S1P and C1P recapitulates the temporal and spatial activation of cPLA(2) and with COX-2 seen IL-1beta. Taken together, the results provide, for the first time, a mechanism that assures the coordinate expression and activation in time and space of COX-2 and cPLA(2), assuring maximal production of PGE(2).
Pettus
Benjamin J
BJ
Department of Biochemistry and Molecular Biology, Room 501, Basic Science Building, Medical University of South Carolina, 173 Ashley Avenue, P.O. Box 250509, Charleston, SC 29425, USA. hannun@musc.edu
Kitatani
Kazuyuki
K
Chalfant
Charles E
CE
Taha
Tarek A
TA
Kawamori
Toshihiko
T
Bielawski
Jacek
J
Obeid
Lina M
LM
Hannun
Yusuf A
YA
D045744:Cell Line, Tumor; D002518:Ceramides / Q000494:pharmacology / Q000502:physiology*; D015232:Dinoprostone / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D008246:Lysophospholipids / Q000494:pharmacology / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000502:physiology*
D002518:Ceramides; D008246:Lysophospholipids; C065576:ceramide 1-phosphate; C060506:sphingosine 1-phosphate; D015232:Dinoprostone; D013110:Sphingosine